Published online Jul 24, 2023. doi: 10.5306/wjco.v14.i7.259
Peer-review started: February 23, 2023
First decision: March 28, 2023
Revised: May 10, 2023
Accepted: June 13, 2023
Article in press: June 13, 2023
Published online: July 24, 2023
Processing time: 145 Days and 14.1 Hours
Despite the occurrence of approximately 50000 new cases of anal cancer per year and the clear link with smoking, very few studies have examined the relationship between smoking status and treatment outcome. It has already been shown that there is a link between anal cancer and smoking. This paper goes further and showed that there was an increased risk of recurrence in patients who smoke and have a history of smoking. This serves as a foundation for future research to examine modifications to the current treatment approach for patients with anal cancer.
Investigating the relationship between cigarette smoking status and anal cancer treatment outcome.
The main objective of this study was to examine the relationship between smoking status and outcomes for patients with anal cancer.
A total of 95 patients were included in this data, making it the second largest study to examine the impact of smoking on anal cancer treatment outcomes. The patients were similar between the groups (never smokers, former smokers, and current smokers) in regards to important factors such as clinical stage group, race, and sex. Former and current smokers had a higher recurrence rate compared to never smokers. There was no difference in the mortality, non-response rate, or time to death between the groups. Unfortunately, data did not include human papilloma virus status, which would be an important area to include for future research.
There was an increased risk of anal cancer recurrence in patients who currently smoke and have a history of smoking.
This study was the second largest study examining the relationship between treatment outcome and smoking status in patients with anal cancer. Although this data was limited in its scope, it contributed further to the limited body of evidence that smoking increases risk of recurrence of anal cancer.
Future research should examine the impact of smoking cessation on treatment outcomes for patients with anal cancer as well as the role of adjuncts to standard chemoradiation in the treatment of anal cancer.